This file contains the raw clinical parameters used in the comparative analysis between CHB patients with concurrent MASLD and healthy control subjects. (XLSX)
Characteristics are shown for all patients as well as inactive HBsAg carriers (n = 48) and active CHB patients (n = 46) in whom longitudinal data were available.IC, inactive HBsAg carriers; CHB, activ
*Patient sera were tested for hepatitis A virus IgM, hepatitis C virus antibody, hepatitis D virus antigen, hepatitis D virus antibody, and hepatitis E virus IgM.
